The 12 closest competitors and alternatives to OncoZenge among health care companies — ranked by similarity to what OncoZenge actually does, not by market-cap band.
Subscribe to see OncoZenge’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
OncoZenge is a pharmaceutical development company that creates targeted treatments for oral pain, primarily focusing on oral mucositis caused by cancer radiotherapy and chemotherapy. Its lead product candidate, BupiZenge, is a bupivacaine-based lozenge designed to provide safe, local, and non-opioid pain relief for patients.
OncoZenge is a health care company headquartered in Sweden. Xcout tracks 6 named people at OncoZenge, including Stian Kildal (CEO).
Ranked by semantic similarity — how close each company is to OncoZenge by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar health care company
Sprint Bioscience is a pharmaceutical company that develops innovative preclinical drug candidates for cancer treatments. Utilizing a fragment-based drug discovery method, the company creates and out-licenses its drug programs to global pharmaceutical partners.
Healthcare
Oral Biolife is an innovative biotech company that develops first-in-class piezoelectric therapies converting mechanical force into bone regeneration. Headquartered in Bethlehem, Pennsylvania, the firm is transforming periodontal treatments with products such as Ambrilux Dental Gel.
Healthcare
Brise Pharmaceuticals Co., Ltd. is a pioneering biopharmaceutical company specializing in the discovery and development of innovative treatments for chronic pain. The company is led by expert research professionals and focuses on advancing clinical therapeutics. It is headquartered in Shanghai, China.
Similar health care company
Spago Nanomedical is a clinical-stage pharmaceutical company that develops precision nanomedicine products for the diagnosis and treatment of cancer and other severe diseases. Its pipeline includes Tumorad, a targeted radionuclide therapy for various cancers, and SpagoPix, a polymeric contrast agent designed to improve the precision of MRI diagnostics.
Similar health care company
FluoGuide is a biotechnology company that develops products for precision cancer surgery to improve patient outcomes. Its lead product, FG001, illuminates cancerous tissue during procedures to help surgeons perform more precise operations and reduce cancer recurrence.
Similar health care company
Enzymatica develops health solutions and barrier technology products, such as the ColdZyme mouth spray, designed to support the body's defense against viruses and micro-organisms. The company serves consumers looking to prevent or alleviate common cold symptoms and respiratory infections.
Similar health care company
Orion Oyj is a pharmaceutical and healthcare company that develops, manufactures, and markets medicines, active pharmaceutical ingredients, self-care products, and animal health products. The company serves patients, healthcare professionals, and animal owners by focusing on therapeutic areas such as oncology, respiratory diseases, neurology, women's health, and pain management.
Healthcare
AtomVie Global Radiopharma Inc. is a radiopharmaceutical company headquartered in Hamilton, Ontario, Canada. It operates in the pharmaceutical industry, providing specialized products and services related to global radiopharmaceuticals.
Healthcare
Oruka Therapeutics, Inc. is a biopharmaceutical company dedicated to developing novel biologics designed to establish a new treatment standard for chronic skin diseases.
Biotechnology
St. James Therapeutics is a clinical-stage biopharmaceutical company that develops specialized topical skincare products to treat chemotherapy-induced side effects, specifically hand-foot syndrome. The company serves cancer patients by creating science-backed solutions designed to make cancer treatment more tolerable.
Pharmaceuticals
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for OncoZengeand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →